Skip to main navigation Skip to search Skip to main content

CYP2D6 Genotyping and Antipsychotic-Associated Extrapyramidal Adverse Effects in a Randomized Trial of Aripiprazole Versus Quetiapine Extended Release in Children and Adolescents, Aged 12-17 Years, With First Episode Psychosis

  • Ditte Rudå*
  • , Karsten Gjessing Jensen
  • , Marie Stentebjerg Decara
  • , Dea Gowers Klauber
  • , Birgitte Fagerlund
  • , Jens Richardt Møllegaard
  • , Kristian Linnet
  • , Thomas Werge
  • , Christoph U Correll
  • , Anders Fink-Jensen
  • , Gesche Jürgens
  • , Anne Katrine Pagsberg
  • *Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

Fingerprint

Explore the research areas of 'CYP2D6 Genotyping and Antipsychotic-Associated Extrapyramidal Adverse Effects in a Randomized Trial of Aripiprazole Versus Quetiapine Extended Release in Children and Adolescents, Aged 12-17 Years, With First Episode Psychosis'.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science